UK Pharma Pays Over €200M for a German Drug Against Biliary Cancer
Mundipharma has acquired the rights to CAP7.1, a drug that could bring the first alternative…
14/08/2017 - 2 minutes
Mundipharma has acquired the rights to CAP7.1, a drug that could bring the first alternative…
Heptares is expanding into a range of indications with its GPCR platform. I caught up…
Academic, entrepreneur and now venture partner Trevor Baglin discusses his successful experience working with…
SuperX has raised €10.3M ($11M) in Series A from Medicxi and J&J Innovation to develop…